First-in-human phase Ia study of the PI3Kα inhibitor CYH33 in patients with solid tumors

por Wei, Xiao-Li, Liu, Fu-Rong, Liu, Ji-Hong, Zhao, Hong-Yun, Zhang, Yang, Wang, Zhi-Qiang, Qiu, Miao-Zhen, Xu, Fei, Yu, Qiu-Qiong, Du, Yi-Wu, Shi, Yan-Xia, Wang, De-Sheng, Wang, Feng-Hua, Xu, Rui-Hua
Publicado 2022